Brian Skorney
Stock Analyst at Robert W. Baird
(0.09)
# 4,706
Out of 5,010 analysts
827
Total ratings
34.7%
Success rate
-7%
Average return
Main Sectors:
Stocks Rated by Brian Skorney
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MIRM Mirum Pharmaceuticals | Reiterated: Buy | $123 → $130 | $87.54 | +48.50% | 45 | Sep 29, 2026 | |
| XENE Xenon Pharmaceuticals | Reiterated: Buy | $97 → $90 | $37.25 | +141.61% | 7 | Sep 18, 2026 | |
| DYN Dyne Therapeutics | Reiterated: Buy | $32 → $26 | $16.21 | +60.39% | 3 | Sep 9, 2026 | |
| CLYM Climb Bio | Reiterated: Buy | $25 | $11.50 | +117.39% | 1 | Sep 3, 2026 | |
| ALMS Alumis | Reiterated: Buy | $17 → $27 | $7.29 | +270.37% | 4 | Sep 1, 2026 | |
| RGNX REGENXBIO | Reiterated: Buy | $32 → $29 | $7.45 | +289.26% | 19 | Aug 25, 2026 | |
| PRAX Praxis Precision Medicines | Reiterated: Buy | $400 → $514 | $281.00 | +82.92% | 4 | Aug 7, 2026 | |
| AMGN Amgen | Reiterated: Sell | $215 → $230 | $423.64 | -45.71% | 52 | Aug 5, 2026 | |
| JAZZ Jazz Pharmaceuticals | Reiterated: Buy | $252 → $280 | $232.35 | +20.51% | 3 | Aug 4, 2026 | |
| NBIX Neurocrine Biosciences | Reiterated: Buy | $186 → $225 | $138.35 | +62.63% | 53 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $742 → $761 | $750.51 | +1.40% | 64 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $320 → $350 | $526.73 | -33.55% | 59 | Jul 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $38 → $36 | $26.58 | +35.44% | 15 | May 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $241 → $246 | $186.14 | +32.16% | 3 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $22 → $20 | $18.64 | +7.30% | 108 | Feb 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $108 → $145 | $151.28 | -4.15% | 81 | Feb 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $255 → $250 | $227.07 | +10.10% | 97 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $57 → $52 | $13.29 | n/a | 13 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $30 | $9.75 | n/a | 1 | Dec 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $26 → $20 | $12.64 | n/a | 37 | Nov 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28 | $3.42 | n/a | 5 | Nov 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $4 | $4.69 | n/a | 24 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $26 | $23.68 | n/a | 1 | Sep 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $28 → $30 | $2.60 | n/a | 11 | Dec 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28 | $25.51 | n/a | 7 | Nov 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $7.5 | $0.298 | n/a | 14 | Nov 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $6 | $33.46 | n/a | 16 | Sep 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 | $23.48 | n/a | 14 | Mar 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 | $9.53 | n/a | 2 | Aug 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $34 | $7.05 | n/a | 1 | Aug 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $39 | $1.47 | n/a | 6 | Aug 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $85 → $146 | $12.03 | n/a | 5 | Aug 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $6 | $2.64 | n/a | 11 | May 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $19.37 → $8.30 | $2.31 | n/a | 4 | Jul 7, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 → $3 | $0.829 | n/a | 8 | Nov 1, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $144 | $50.37 | n/a | 1 | Mar 27, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $83 → $138 | $365.27 | n/a | 5 | Feb 28, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $32 → $42 | $115.63 | n/a | 2 | Jan 4, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $115 | $59.87 | n/a | 11 | Oct 3, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $14 → $13 | $21.11 | n/a | 7 | Jul 26, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 | $3.35 | n/a | 3 | Jan 22, 2015 |
Mirum Pharmaceuticals
Sep 29, 2026
Reiterated: Buy
Price Target: $123 → $130
Current: $87.54
Upside: +48.50%
Xenon Pharmaceuticals
Sep 18, 2026
Reiterated: Buy
Price Target: $97 → $90
Current: $37.25
Upside: +141.61%
Dyne Therapeutics
Sep 9, 2026
Reiterated: Buy
Price Target: $32 → $26
Current: $16.21
Upside: +60.39%
Climb Bio
Sep 3, 2026
Reiterated: Buy
Price Target: $25
Current: $11.50
Upside: +117.39%
Alumis
Sep 1, 2026
Reiterated: Buy
Price Target: $17 → $27
Current: $7.29
Upside: +270.37%
REGENXBIO
Aug 25, 2026
Reiterated: Buy
Price Target: $32 → $29
Current: $7.45
Upside: +289.26%
Praxis Precision Medicines
Aug 7, 2026
Reiterated: Buy
Price Target: $400 → $514
Current: $281.00
Upside: +82.92%
Amgen
Aug 5, 2026
Reiterated: Sell
Price Target: $215 → $230
Current: $423.64
Upside: -45.71%
Jazz Pharmaceuticals
Aug 4, 2026
Reiterated: Buy
Price Target: $252 → $280
Current: $232.35
Upside: +20.51%
Neurocrine Biosciences
Jul 31, 2026
Reiterated: Buy
Price Target: $186 → $225
Current: $138.35
Upside: +62.63%
Jul 31, 2026
Reiterated: Hold
Price Target: $742 → $761
Current: $750.51
Upside: +1.40%
Jul 7, 2026
Reiterated: Sell
Price Target: $320 → $350
Current: $526.73
Upside: -33.55%
May 18, 2026
Reiterated: Buy
Price Target: $38 → $36
Current: $26.58
Upside: +35.44%
May 5, 2026
Reiterated: Buy
Price Target: $241 → $246
Current: $186.14
Upside: +32.16%
Feb 26, 2026
Reiterated: Hold
Price Target: $22 → $20
Current: $18.64
Upside: +7.30%
Feb 11, 2026
Reiterated: Hold
Price Target: $108 → $145
Current: $151.28
Upside: -4.15%
Oct 31, 2025
Reiterated: Buy
Price Target: $255 → $250
Current: $227.07
Upside: +10.10%
Aug 12, 2025
Reiterated: Buy
Price Target: $57 → $52
Current: $13.29
Upside: n/a
Dec 12, 2024
Initiated Coverage: Buy
Price Target: $30
Current: $9.75
Upside: n/a
Nov 26, 2024
Reiterated: Buy
Price Target: $26 → $20
Current: $12.64
Upside: n/a
Nov 20, 2024
Reiterated: Buy
Price Target: $28
Current: $3.42
Upside: n/a
Nov 6, 2024
Reiterated: Hold
Price Target: $4
Current: $4.69
Upside: n/a
Sep 5, 2024
Initiated Coverage: Buy
Price Target: $26
Current: $23.68
Upside: n/a
Dec 14, 2023
Downgraded: Hold
Price Target: $28 → $30
Current: $2.60
Upside: n/a
Nov 10, 2022
Reiterated: Buy
Price Target: $28
Current: $25.51
Upside: n/a
Nov 10, 2022
Reiterated: Hold
Price Target: $7.5
Current: $0.298
Upside: n/a
Sep 8, 2022
Reiterated: Hold
Price Target: $6
Current: $33.46
Upside: n/a
Mar 31, 2022
Reiterated: Buy
Price Target: $15
Current: $23.48
Upside: n/a
Aug 12, 2021
Reiterated: Buy
Price Target: $16
Current: $9.53
Upside: n/a
Aug 12, 2021
Initiated Coverage: Buy
Price Target: $34
Current: $7.05
Upside: n/a
Aug 6, 2021
Rated: Buy
Price Target: $39
Current: $1.47
Upside: n/a
Aug 5, 2021
Reiterated: Hold
Price Target: $85 → $146
Current: $12.03
Upside: n/a
May 10, 2021
Reiterated: Hold
Price Target: $6
Current: $2.64
Upside: n/a
Jul 7, 2020
Reiterated: Buy
Price Target: $19.37 → $8.30
Current: $2.31
Upside: n/a
Nov 1, 2018
Reiterated: Buy
Price Target: $7 → $3
Current: $0.829
Upside: n/a
Mar 27, 2018
Reiterated: Buy
Price Target: $144
Current: $50.37
Upside: n/a
Feb 28, 2018
Reiterated: Hold
Price Target: $83 → $138
Current: $365.27
Upside: n/a
Jan 4, 2018
Reiterated: Buy
Price Target: $32 → $42
Current: $115.63
Upside: n/a
Oct 3, 2017
Reiterated: Buy
Price Target: $115
Current: $59.87
Upside: n/a
Jul 26, 2017
Reiterated: Hold
Price Target: $14 → $13
Current: $21.11
Upside: n/a
Jan 22, 2015
Reiterated: Buy
Price Target: $11
Current: $3.35
Upside: n/a